ARIEL SOUTHEAST ANGEL PARTNERS
Ariel Southeast Angel Partners is an angel investment group that supports start-up and early stage companies.
ARIEL SOUTHEAST ANGEL PARTNERS
Status:
Active
Contact:
912-656-5603
Technology used in webpage:
SPF Apache Pound Sterling Japanese Yen Citrix NetScaler Confluence Networks Data Foundry
Similar Organizations
TiE Angels
TiE Angels is an angel investment group supporting top-tier emerging companies with early stage investment and advice.
Current Advisors List
Jim Goodlet Board of Directors Member / Angel Investor Member / Technology Due Diligence Team Member @ Ariel Southeast Angel Partners Board_member 2009-10-01
Current Employees Featured
Nancy Matthews
Nancy Matthews Director @ Ariel Southeast Angel Partners Director
Ray Wenig
Ray Wenig President and Chief Operating Officer @ Ariel Southeast Angel Partners President and Chief Operating Officer 2006-01-01
Steve Clark
Steve Clark Chairman @ Ariel Southeast Angel Partners Chairman
Joe Isola
Joe Isola Director @ Ariel Southeast Angel Partners Director
Bill Tausig
Bill Tausig Treasurer and Secretary @ Ariel Southeast Angel Partners Treasurer and Secretary
J. BLAKE LONG
J. BLAKE LONG Investor Member/Life Sciences Due Diligence @ Ariel Southeast Angel Partners Investor Member/Life Sciences Due Diligence 2011-07-01
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-09-15 | Skintelligent | Ariel Southeast Angel Partners investment in Pre Seed Round - Skintelligent | 250 K USD |
2019-09-26 | Zylรถ Therapeutics | Ariel Southeast Angel Partners investment in Series A - Zylรถ Therapeutics | 4 M USD |
2019-06-17 | New View Surgical | Ariel Southeast Angel Partners investment in Series A - New View Surgical | 2.1 M USD |
2018-07-01 | RevBio | Ariel Southeast Angel Partners investment in Convertible Note - RevBio | 4 M USD |
2017-03-01 | New View Surgical | Ariel Southeast Angel Partners investment in Series A - New View Surgical | 2.54 M USD |
2015-09-08 | Cognition Therapeutics | Ariel Southeast Angel Partners investment in Series B - Cognition Therapeutics | 12 M USD |